Franklin Street Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Franklin Street Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,333	Closed	-$10K	–	169
2018 Q1	$10K	Hold	3,333	–	–	﹤0.01%	164
2017 Q4	$11K	Hold	3,333	–	–	﹤0.01%	165
2017 Q3	$51K	Hold	3,333	–	–	0.01%	155
2017 Q2	$67K	Hold	3,333	–	–	0.01%	145
2017 Q1	$33K	Hold	3,333	–	–	0.01%	159
2016 Q4	$32K	Hold	3,333	–	–	0.01%	170
2016 Q3	$36K	Hold	3,333	–	–	0.01%	179
2016 Q2	$58K	Hold	3,333	–	–	0.01%	195
2016 Q1	$125K	Buy	+3,333	New	+$133K	0.02%	213
2014 Q4	–	Sell	-6,163	Closed	-$268K	–	231
2014 Q3	$268K	Sell	6,163 -114	-2%	-$5.34K	0.05%	202
2014 Q2	$376K	Buy	6,277 +1,680	+37%	+$93.7K	0.07%	171
2014 Q1	$361K	Buy	4,597 +3,397	+283%	+$263K	0.07%	177
2013 Q4	$73K	Buy	+1,200	New	+$69.8K	0.01%	223

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Street Advisors's FCSC Position: Q2 2018 in Review

Franklin Street Advisors sold out of Fibrocell Science Inc. (FCSC) in Q2 2018, closing a stake of 3,333 shares — an estimated $10K sold.

Franklin Street Advisors first reported a position in FCSC in Q4 2013 and held it in 13 quarters. The position peaked at $376K in Q2 2014. 25 funds tracked by Wall St. Rank hold FCSC as of Q2 2018.

Franklin Street Advisors reported no remaining Fibrocell Science Inc. position as of Q2 2018 after selling out during the quarter.
Franklin Street Advisors sold 3,333 Fibrocell Science Inc. shares in Q2 2018, an estimated $10K.
Franklin Street Advisors first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 13 quarters.
Franklin Street Advisors's Fibrocell Science Inc. position peaked at $376K in Q2 2014.
25 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2018.

Based on Franklin Street Advisors's 13F filing for Q2 2018, filed 16 Jul 2018.